康健國際醫療(03886.HK)14.18億股遭凍結
康健國際醫療(03886.HK)公布,公司近期獲知會,英屬維爾京群島高等法院之東加勒比最高法院,已授出針對Broad Idea International Limited之凍結令,Broad Idea被限制以任何方式出售、處置或縮減其任何資產之價值,凍結令所涉及Broad Idea之資產包括Broad Idea持有
之14.18億股公司股份(即已發行股份之18.85%)或其銷售所得款項。直至法
院進一步頒令前,凍結令將具有法律效力。公司正在就此事宜尋求法律意見。
公司認為凍結令將不會對本集團於本公告日期之業務營運或財務狀況造成任何重大不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.